{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:52:02Z","timestamp":1784605922853,"version":"3.55.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"DOI":"10.1210\/jc.2008-2446","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T21:13:39Z","timestamp":1240953219000},"page":"2269-2276","source":"Crossref","is-referenced-by-count":43,"title":["Osteoclastogenesis in Children with 21-Hydroxylase Deficiency on Long-Term Glucocorticoid Therapy: The Role of Receptor Activator of Nuclear Factor-\u03baB Ligand\/Osteoprotegerin Imbalance"],"prefix":"10.1210","volume":"94","author":[{"given":"Maria Felicia","family":"Faienza","sequence":"first","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Brunetti","sequence":"additional","affiliation":[{"name":"Human Anatomy and Histology (G.B., S.C., M.G.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Colucci","sequence":"additional","affiliation":[{"name":"Human Anatomy and Histology (G.B., S.C., M.G.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piacente","sequence":"additional","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Giordani","sequence":"additional","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Carlo","family":"Del Vecchio","sequence":"additional","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"D'Amore","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Public Medicine (M.D., L.A.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Albanese","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Public Medicine (M.D., L.A.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Departments of Biomedicine of Developmental Age (M.F.F., L.P., M.C., L.G., G.C.D.V., L.C.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grano","sequence":"additional","affiliation":[{"name":"Human Anatomy and Histology (G.B., S.C., M.G.), Section of Rheumatology, University of Bari, 70100 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113342670000_R1","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113342670000_R2","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","article-title":"Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","article-title":"Glucocorticoid-induced osteoporosis: an update.","volume":"17","author":"Mazziotti","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy.","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113342670000_R5","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1203\/00006450-199305001-00467","article-title":"Increased bone mineral density in congenital adrenal hyperplasia","volume":"33","author":"Speiser","year":"1993","journal-title":"Pediatr Res"},{"key":"key\n\t\t\t\t2019041113342670000_R6","first-page":"2238","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia.","volume":"80","author":"Cameron","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency.","volume":"45","author":"Jaaskelainen","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342670000_R8","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density and bone turnover markers in children with congenital adrenal hyperplasia.","volume":"82","author":"Girgis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1530\/eje.0.1430667","article-title":"Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy.","volume":"143","author":"Hagenfeldt","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342670000_R10","first-page":"164","article-title":"Height, bone mineral density and bone markers in congenital adrenal hyperplasia.","volume":"54","author":"Paganini","year":"2000","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113342670000_R11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00774-003-0434-6","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross selectional study of factors involved in bone mineral density.","volume":"21","author":"Freire","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jc.2005-0745","article-title":"Long term glucocorticoid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.","volume":"91","author":"King","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R13","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1210\/jc.2005-2823","article-title":"Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase.","volume":"91","author":"Sciannamblo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.","volume":"45","author":"Guo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113342670000_R15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/8756-3282(96)00003-8","article-title":"Bone density in young patients with congenital adrenal hyperplasia.","volume":"18","author":"Mora","year":"1996","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113342670000_R16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.","volume":"100","author":"Gussinye\u0300","year":"1997","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113342670000_R17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113342670000_R18","first-page":"133","article-title":"Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"61","author":"Christiansen","year":"2004","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113342670000_R19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","article-title":"Human osteoclasts derive from CD14-positive monocytes.","volume":"106","author":"Massey","year":"1999","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019041113342670000_R20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation.","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113342670000_R21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: T cells, bone loss, and mammalian evolution.","volume":"20","author":"Theill","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t2019041113342670000_R22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113342670000_R23","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-02-0474","article-title":"T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction.","volume":"104","author":"Colucci","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113342670000_R24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s001980050281","article-title":"An update on the diagnosis and assessment of osteoporosis with densitometry.","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113342670000_R25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis\u2014mechanisms and management.","volume":"137","author":"Reid","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113342670000_R26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jbmr.5650111008","article-title":"Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.","volume":"11","author":"Conaway","year":"1996","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113342670000_R27","first-page":"137","article-title":"Bone histomorphometry in glucocorticoid-induced osteoporosis.","volume":"13","author":"Dempster","year":"1998","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113342670000_R28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanism of their deleterious effects on bone.","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113342670000_R29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","article-title":"Influence of glucocorticoids on human osteoclast generation and activity.","volume":"20","author":"Sivagurunathan","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113342670000_R30","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113342670000_R31","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1210\/endo.133.5.7691583","article-title":"Abnormalities in osteoclast precursors and marrow accessory cells in Paget\u2019s disease.","volume":"133","author":"Demulder","year":"1993","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113342670000_R32","first-page":"1392","article-title":"Osteoclast precursors circulate in the peripheral blood of patients with aggressive multiple myeloma.","volume":"9","author":"Gregoretti","year":"1995","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t2019041113342670000_R33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-\u03b1- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113342670000_R34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1096\/fj.04-1823fje","article-title":"Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.","volume":"19","author":"Roato","year":"2005","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019041113342670000_R35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","article-title":"Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor \u03baB ligand on adult T-cell leukemia cells.","volume":"99","author":"Nosaka","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113342670000_R36","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1182\/blood-2002-04-1121","article-title":"Human myeloma cells stimulate the receptor activator of nuclear factor-\u03baB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.","volume":"100","author":"Giuliani","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041113342670000_R37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113342670000_R38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-051X.2007.01061.x","article-title":"Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.","volume":"34","author":"Bostanci","year":"2007","journal-title":"J Clin Periodontol"},{"key":"key\n\t\t\t\t2019041113342670000_R39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/03009740510026788","article-title":"The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.","volume":"34","author":"Kobayashi","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"key\n\t\t\t\t2019041113342670000_R40","first-page":"S4","article-title":"RANK ligand inhibition by Denosumab prevents cortical bone loss in a murine model of glucocorticoid-induced osteoporosis.","volume":"22","author":"Hofbauer","year":"2007","journal-title":"Proc 29th Annual Meeting of the ASBMR J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/7\/2269\/9063462\/jcem2269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T14:59:57Z","timestamp":1558277997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/7\/2269\/2596425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2446","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}